GOLDMAN SACHS GROUP INC - PARDES BIOSCIENCES INC ownership

PARDES BIOSCIENCES INC's ticker is and the CUSIP is 69945Q105. A total of 61 filers reported holding PARDES BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of PARDES BIOSCIENCES INC
ValueSharesWeighting
Q2 2023$1,517,435
+40.8%
838,362
+2.7%
0.00%
Q1 2023$1,077,379
-70.8%
816,196
-62.6%
0.00%
-100.0%
Q4 2022$3,689,951
-65.8%
2,183,403
-62.5%
0.00%
-50.0%
Q3 2022$10,785,000
-17.8%
5,829,671
+36.3%
0.00%
-33.3%
Q2 2022$13,127,000
-13.9%
4,275,914
+102.4%
0.00%0.0%
Q1 2022$15,252,0002,112,4110.00%
Other shareholders
PARDES BIOSCIENCES INC shareholders Q1 2023
NameSharesValueWeighting ↓
Foresite Capital Opportunity Management V, LLC 5,227,307$16,048,00040.44%
Foresite Capital Management V, LLC 9,400,515$28,860,00020.16%
Lynx1 Capital Management LP 2,180,560$6,694,0005.70%
VK Services, LLC 6,151,766$18,886,0002.82%
Arena Capital Advisors, LLC- CA 851,281$2,613,0000.66%
RA Capital Management 6,175,038$18,957,0000.50%
DAFNA Capital Management LLC 451,105$1,385,0000.38%
Sio Capital Management, LLC 315,564$969,0000.36%
Chescapmanager LLC 361,716$1,110,0000.26%
Frazier Life Sciences Management, L.P. 845,636$2,596,0000.24%
View complete list of PARDES BIOSCIENCES INC shareholders